Business Context and Reporting Period
Company: Gilead Sciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 8, 2024
Reporting Period: Quarter ended June 30, 2024
This filing serves as a notification that Gilead Sciences, Inc. issued a press release on August 8, 2024, announcing its financial results for the second quarter of 2024. The detailed financial data is contained within the press release filed as Exhibit 99.1.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The filing explicitly states that these metrics are presented in the attached press release (Exhibit 99.1) on both GAAP and non-GAAP bases. Management utilizes non-GAAP measures for internal operating, budgeting, and financial planning purposes.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. Investors must refer to the press release in Exhibit 99.1 for comparative analysis and reconciliation tables between GAAP and non-GAAP financial information.
Guidance, Outlook, and Risks
Management Commentary: Management asserts that non-GAAP information is useful for investors when considered alongside GAAP statements but notes that non-GAAP measures may be defined differently by other industry peers.
Legal Disclaimer: The information in Item 2.02 and Item 9.01, including the press release, is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section. It shall not be incorporated by reference into any other filings under the Securities Act or Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q2 2024 revenue, net income, and cash flow figures.
- Examine the reconciliation tables on pages 10, 11, and 12 of the press release to understand adjustments between GAAP and non-GAAP metrics.
- Verify the specific details of the "Results of Operations and Financial Condition" which are referenced but not detailed in this 8-K summary.
- Note that the financial data in this filing is not legally "filed" for liability purposes under Section 18 of the Exchange Act.